Adjuvant everolimus in high-risk diffuse large B-cell lymphoma: final results from the PILLAR-2 randomized phase III trial
Titel:
Adjuvant everolimus in high-risk diffuse large B-cell lymphoma: final results from the PILLAR-2 randomized phase III trial
Auteur:
Witzig, T.E. Tobinai, K. Rigacci, L. Ikeda, T. Vanazzi, A. Hino, M. Shi, Y. Mayer, J. Costa, L.J. Bermudez Silva, C.D. Zhu, J. Belada, D. Bouabdallah, K. Kattan, J.G. Kuruvilla, J. Kim, W.S. Larouche, J.-F. Ogura, M. Ozcan, M. Fayad, L. Wu, C. Fan, J. Louveau, A.-L. Voi, M. Cavalli, F.